Cat. No. | Product name | CAS No. |
DCC1588 |
Ctr-21
Novel anticancer agent, effectively killing multi-drug resistant cancer cells and a panel of different cancer cells originated from a variety of different tissues including breast and skin, preventing tubulin polymerization, leading to the cell cycle arre |
2098310-96-2 |
DCC1589 |
Ctr-32
Novel anticancer agent, effectively killing multi-drug resistant cancer cells and a panel of different cancer cells originated from a variety of different tissues including breast and skin, preventing tubulin polymerization, leading to the cell cycle arre |
|
DCC1590 |
Ctt-54.2 Potassium
Inhibitor of prostate-specific membrane antigen (PSMA) |
1291095-95-8 |
DCC1591 |
Ctw0415
Novel Serotonin 5-HT 2C Receptor Positive Allosteric Modulator (PAM) with Enhanced Drug-like Properties |
|
DCC1592 |
Cu-6pmn
Novel fluorescent RXR agonist |
|
DCC1593 |
Cugamycin
Novel r(CUG) repeat expansion cleaver, specifically recognizing the 3-dimensional structure of r(CUG)exp, cleaving it more selectively among transcripts containing short, nonpathogenic r(CUG) repeats than an oligonucleotide that recognizes RNA sequence vi |
|
DCC1594 |
Cumi-101
5-HT1A receptor agonist |
179756-61-7 |
DCC1595 |
Cumyl-pica
Agonist for the cannabinoid receptors, with Ki values of 59.21 nM at CB1 and 136.38 nM at CB2 and EC50 values of 11.98 nM at CB1 and 16.2 nM at CB2 |
1400742-32-6 |
DCC1596 |
Cuprizone
Inducer of demyelination and motor dysfunction via upregulation of IGF-1 |
370-81-0 |
DCC1597 |
Cv21/jr95
Potent anti-cancer agent |
1353182-67-8 |
DCC1598 |
Cvk-003
Novel dual PXR and AhR agonist |
|
DCC1599 |
Cvk-021
Novel potent pregnane X Receptor (PXR) agonist |
|
DCC1600 |
Cvm-04-70
Inhibitor of PIM, suppressing cyclin-Dependent Kinase 2 (CDK2) |
|
DCC1601 |
Cvm-05-002
Novel potent and selective inhibitor of PI5P4Ks |
|
DCC1602 |
Cvs-1123
Direct thrombin inhibitor, preventing occlusive arterial and venous thrombosis in a canine model of vascular injury |
151275-19-3 |
DCC1603 |
Cvs-1578
Potent serine protease inhibitor, targeting the S 2 S 3 thrombin and FXa subsites |
186318-81-0 |
DCC1604 |
Cwhm-1552
Novel orally efficacious antimalarial agent against P. falciparum 3D7 ( IC50: 51 nM) |
2368253-58-9 |
DCC1605 |
Cwhm-505
Potent antimalarial agent against Plasmodium falciparum 3D7 |
1695611-59-6 |
DCC1606 |
Cwhm-505 Hydrochloride
Potent antimalarial agent against Plasmodium falciparum 3D7 |
1695560-60-1 |
DCC1607 |
Cwp231904
Novel Wnt/β-Catenin Inhibitor, Preferentially Inhibiting the Growth of Breast Cancer Stem-like Cells |
|
DCC1608 |
Cx08005
Novel potent and substrate-competitive PTP1B and TCPTP dual inhibitor |
1256341-22-6 |
DCC1609 |
Moxilubant Maleate
Potent LTB4 receptor antagonist |
147398-01-4 |